Cite
HARVARD Citation
Ruzzolini, J. et al. (2017). Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH. Cancer letters. pp. 43-54. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ruzzolini, J. et al. (2017). Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH. Cancer letters. pp. 43-54. [Online].